- Investing Ideas
- Belgian Pharmaceuticals & Biotech Potentially Undervalued Companies
Belgian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
2
0 new
Companies with a Value score of at least 3, ordered by Value score
2 companies
UCB
Market Cap: €41.1b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€215.40
7D
-4.3%
1Y
10.2%
argenx
Market Cap: €45.7b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€855.20
7D
11.5%
1Y
49.1%